Update_on_lobular_lesions_of_the_breast,_Histopathology_10_1111his
Page 1: Introduction to Lobular Lesions of the Breast
Key Concepts
Histopathology Review: This article discusses lobular lesions, including histological classifications, diagnostic criteria, and treatment implications for invasive lobular carcinoma (ILC).
Focus Areas:
Diagnostic criteria for non-invasive lobular neoplasia (LN).
Role of immunohistochemistry (IHC).
Newly described variants of ILC.
Clinicopathological features relevant for clinical management.
Background
History: ILC was first described by Foote and Stewart in 1941, distinguishing it from ductal carcinomas.
Morphological Classification: The spectrum of lobular carcinoma includes classic lobular carcinoma in situ (LCIS) and infiltrative lobular carcinoma (ILC).
Non-invasive Lobular Neoplasia (LN)
Types:
Atypical lobular hyperplasia (ALH)
Lobular carcinoma in situ (LCIS)
Morphological Characteristics: Unified definition of the types of cells involved, such as Type A and Type B cells that differ in size and nuclear characteristics.
Significance of E-cadherin
Loss of E-cadherin: A hallmark for diagnosing lobular lesions, indicating the loss of cell-to-cell adhesion and associated with inactivation of the CDH1 gene.
Page 2: Classification and Diagnosis of Non-invasive LN
Classification of LCIS
WHO Classification: Defines ALH and LCIS into several categories:
Classic LCIS (CLCIS)
Florid LCIS (FLCIS)
Pleomorphic LCIS (PLCIS)
Diagnostic Criteria: Focus on the architectural patterns and extent of lobular involvement.
Differential Diagnosis: Key distinctions from ductal carcinoma in situ (DCIS), with morphological overlap and clinical implications.
Clinical Implications
Management: Notable differences in management strategies across various healthcare guidelines based on pathological findings.
Page 3: Morphological Features of Non-invasive LN
Morphological Features Summary
Table 1 summarizes the features of ALH, CLCIS, FLCIS, and PLCIS, detailing cytological, architectural, necrosis, and calcifications.
Key Characteristics:
Cytological Features: Non-cohesive characteristics with different nuclear sizes and morphology cues.
Architectural Features: Involvement of ducts and acini noted for various types.
Clinical Significance
Incidence Notes: The frequency of ALH and LCIS indicates higher risks for subsequent breast cancer.
Page 4: Differential Diagnosis
Diagnosis of LCIS vs. DCIS
Key Clues: Observation of necrosis and cell cohesion can aid in distinguishing LCIS from DCIS.
Clinical Scenarios: Presence of necrosis alongside cell types aids in guiding toward appropriate diagnoses.
Management Decisions: The presence or absence of features like comedo-necrosis impacts management strategies.
Page 5: Management Guidelines
Regional Differences in Management
Table 2 outlines management recommendations for classic lobular neoplasia, PLCIS, and FLCIS as per various guidelines (e.g., NCCN, ESMO, NHS).
General Guidelines: Usually emphasizes conservative management but recognizes the need for surgical excision in certain cases.
Treatment Recommendations
Excisions: Recommendations vary, with a general consensus understanding the roles of imaging and follow-up for atypical findings.
Page 6: Reporting and Management of Surgical Specimens
Table 3: Guidelines on Surgical Reporting
Key Findings for Reporting: Emphasis on documenting extent, margin status, and handling of lesions diagnosed as lobular carcinoma in situ.
Management Recommendations: Recommendations on excision and margins provided; notes include granting surgical interventions only in specific cases.
Page 7: Updates on ILC Variants
New Variants of ILC
ILC with Extracellular Mucin (ILCEM): Describes tumors with extracellular mucin production, emphasizing diagnosis and characterization.
Morphological Dilemmas: Discusses the challenges in distinguishing new invasive lobular carcinoma variants via histological examination.
Page 8: Overview of Solid Papillary Growth Patterns
Invasive ILC Characterization
Identification Challenges: Highlighting problems associated with diagnosing ILC with solid papillary patterns amidst mixed histological features.
Examples and Case Studies: Present case studies to exemplify challenges in identification and characterization of ILC with solid papillary features.
Page 9: Mixed Morphological Features in Carcinomas
Dual Phenotypes in Breast Carcinoma
Morphological Characteristics: Description of invasive carcinomas blending IBC-NST with lobular features prompting new classifications.
Histopathological Definitions: Update presented for various cancer types, with emphasis on critical morphological and immunohistochemical criteria.
Page 10: Tubulolobular Carcinoma
Description and Comparisons
Characterization of Tubulolobular Carcinoma: Emphasis on hybrid morphology and potential misdiagnosis as other breast cancer types.
Prognostic Significance: Connection between tumor morphology and clinical behavior highlighted via comparisons across studies.
Page 11: Clinical Diagnosis and Implications
Historical Diagnostic Criteria
Evolution of Classification: Diagnostic criteria for distinguishing lobular features in breast cancer, focusing on the role of E-cadherin.
Clinical Considerations: The need for judicious interpretation of IHC in ambiguous morphologies and potential implications for patient management.
Page 12: Summary of Findings and Recommendations
Conclusion
Diverse Clinical Behaviors: Barriers encountered due to variability in histological patterns and complexities within lobular carcinomas.
Need for Consensus on Diagnostic Guidelines: Acknowledgment of the discrepancies in histopathological criteria across different practices and recommendations for standardization.
Page 13: References
A comprehensive reference list is included for further reading and validation of discussed topics.
Page 14-17: Additional Studies and Observations
Further Observations: Studies that characterize lobular carcinoma variants and differences in clinical presentations and outcomes, reinforcing the necessity of evolving diagnostic standards in pathology.